Carmell Therapeutics Corporation (CTCX) — Cash Flow Quality Index

Latest as of December 2024: -0.07x

Carmell Therapeutics Corporation (CTCX) has a Cash Flow Quality Index of -0.07x as of December 2024. Operating cash flow of $-772.06K is below net income of $10.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Carmell Therapeutics Corporation cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.07x

Operating CF / Net Income

Operating Cash Flow

$-772.06K

USD

Net Income

$10.84 Million

USD

Data as of

Dec 2024

Most recent filing

Annual Cash Flow Quality Index for Carmell Therapeutics Corporation (None–None)

Year-by-year earnings quality comparison for Carmell Therapeutics Corporation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.